Non-small Cell Lung Cancer, Non-squamous
3 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer, Non-squamous
| Record | Firm | Date |
|---|---|---|
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors (NCT04032704) | Seagen Inc. | 2019-10-09 |
Track Non-small Cell Lung Cancer, Non-squamous automatically
Every clearance here is in the API, with alerts when new ones post.